【レポートの概要(一部)】
Table of Contents
Table of Contents 2
List of Tables3
List of Figures 4
Introduction 5
Hypertropic Cardiomyopathy 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Hypertropic Cardiomyopathy to Cardiovascular Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Hypertropic Cardiomyopathy 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Hypertropic Cardiomyopathy Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Gilead Sciences, Inc. 26
Clinical Trial Overview of Gilead Sciences, Inc. 26
Novartis AG 27
Clinical Trial Overview of Novartis AG 27
Heart Metabolics Ltd. 28
Clinical Trial Overview of Heart Metabolics Ltd. 28
A. Menarini Industrie Farmaceutiche Riunite Srl 29
Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl 29
Clinical Trial Overview of Top Institutes / Government 30
National Heart, Lung, and Blood Institute 30
Clinical Trial Overview of National Heart, Lung, and Blood Institute 30
Johns Hopkins University 31
Clinical Trial Overview of Johns Hopkins University 31
University of Miami 32
Clinical Trial Overview of University of Miami 32
Brigham and Women’s Hospital 33
Clinical Trial Overview of Brigham and Women’s Hospital 33
Stanford University 34
Clinical Trial Overview of Stanford University 34
University of Calgary 35
Clinical Trial Overview of University of Calgary 35
Johann Wolfgang Goethe University Hospitals 36
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 36
Massachusetts General Hospital 37
Clinical Trial Overview of Massachusetts General Hospital 37
Duke University 38
Clinical Trial Overview of Duke University 38
Assistance Publique – Hopitaux de Paris 39
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 39
Five Key Clinical Profiles 40
Appendix 56
Abbreviations 56
Definitions 56
Research Methodology 57
Secondary Research 57
About GlobalData 58
Contact Us 58
Disclaimer 58
Source 58
【レポート販売概要】
■ タイトル:肥厚性心筋症(Hypertropic Cardiomyopathy):治療薬のグローバル治験動向(2014年下半期)■ 英文:Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014
■ 発行日:2014年9月21日
■ 調査会社:GlobalData
■ 商品コード:GDHC2336CTIDB
■ 調査対象地域:グローバル
- ゲノミクスの世界市場:ゲノム解析装置、消耗品、シークエンシング、PCR、マイクロアレイThe global genomics market is segmented on the basis of product, technology, process, end user, and application. By product, the market is categorized into instruments/systems, consumables, and services. In 2015, the consumables accounted for the larger share of the market and expected to grow at the fastest rate during the forecast period. The genomics market by technology is broadly classified i …
- エネルギー部門におけるIT支出の世界市場2016-2020:ITサービス、ソフトウェア、ハードウェアAbout IT Spending in Energy Sector IT spending comprises the spending of the enterprise on the procurement of IT solutions and services in the energy sector. Energy firms like the oil and gas companies along with the power companies require IT solutions such as on-premises of cloud-based software solutions, networking devices, equipment, and IT support services. Technavio’s analysts forecast the g …
- 着床前診断の世界市場分析:タイプ別(染色体異常、HLAタイピング、X連鎖疾患、性別の選択、遺伝的障害)、用途別(幹細胞治療用胚HLAタイピング、IVF予後、遅発性遺伝的疾患、遺伝病)、セグメント予測、 – 2024Global preimplantation genetic diagnosisis market expected to reach USD 96.8 million by 2024, according to a new report by Grand View Research, Inc. This expected growth in demand can be ascribed to the growing incidence of inherited single gene associated and late onset genetic disorders. Ongoing introduction of advancements in in-vitro fertilization (IVF) methods are key factors that have a posi …
- ヘアコンディショナーの世界市場2015-2019About Hair Conditioners The global hair conditioner market is dominated by the nonprofessional hair conditioner segment. It is expected to grow steadily during the forecast period, with increased demand from the men’s category. Vendors are providing customised solutions for hair problems and customers are ready to spend on high-quality products that cater to their needs. Even though the Americas g …
- 企業情報管理(EIM)の世界市場2016-2020About the Enterprise Information Management (EIM) Market EIM specializes in finding solutions for optimum information use within enterprises. This may include supporting decision-making processes or daily operations that require useful insights. EIM is used to create and manage databases, enabling organizations to store data in a cost-effective manner. Technavio’s analysts forecast the global ente …
- バイオチップの世界市場分析:タイプ別(DNAチップ、ラボオンチップ、タンパク質チップ、がん診断および治療、遺伝子発現、一塩基多型(SNP)遺伝子型決定、ゲノミクス、薬物発見、農業バイオテクノロジー、プロテオミクス、発現プロファイリング、ハイスループットスクリーニング)、エンドユーザー別別(バイオテクノロジー・製薬企業、病院&診断センター、学術&研究機関)、セグメント予測Global biochips anticipated market to reach USD 25.84 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of personalized medicine and rapid technological advancements in the biochips market along with high market demand from proteomic and genomic applications is expected to drive market growth. Anticipated launch and commercialization of novel products for dia …
- 食事代替食品の世界市場:シェイク、プロテインバー、病み上がり食品About Meal Replacement Meal replacement products provide 200-250 calories per serving and are fortified with more than 20 vitamins and minerals; they do not contain fat or sugar. They are mainly intended for weight control and act as a substitute for a solid meal containing all the major nutrients. They are designed to replace one or two meals per day. Technavio’s analysts forecast the global meal …
- グローバルにおける感染症の分子診断市場:予測、シェア、技術、競争環境Complete report $19,500. DataPack (test volumes, sales forecasts, supplier shares) $12,500. The report is available by country, section, market segment, individual test, and can be custom-tailored to your specific information needs and budget. This new seven-country study from Venture Planning Group contains 775 pages, 73 tables, and is designed to help current supplie …
- コイルドチュービングサービスの世界市場:ウェルインターベンション、掘削サービスThis report estimates the coiled tubing market in terms of value in $Million. This has been segmented into component regions and further split into countries. A Coil Tubing (CT) unit usually comprises a set of equipment to perform standard continuous-length tubing operations in the oil & gas fields. Coiled tubes are generally made of low-alloy carbon-steel and range from 0.75 inches to 4 inches in …
- Floating Production Storage and Offloading (FPSO) Industry – Global Market Analysis, Competitive Landscape and Planned Projects to 2016Floating Production Storage and Offloading (FPSO) Industry - Global Market Analysis, Competitive Landscape and Planned Projects to 2016 Summary “Floating Production Storage and Offloading (FPSO) Industry - Global Market Analysis, Competitive Landscape and Planned Projects to 2016”, is the latest report from GlobalData, the industry analysis specialist, which provides an in-depth analysis of the gl …
- セルベースアッセイ(Cell-based Assay)のグローバル市場動向(~2018)The market for cell-based assays is driven by the preference over biochemical assays and animal models and the emergent 3D cell-based assay techniques in cell-based assays There has been a substantial rise in the costs to develop a new drug in recent years. This is specially observed when a new compound enters animal testing. The use of animals in experimentation is becoming dearer, due to limitat …
- 血液ガス分析装置/電解質分析装置の世界市場予測(~2021)The global blood gas analyzer market is expected to reach USD 636.0 Million by 2021 from USD 506.9 Million in 2016, at a CAGR of 4.6%. Growth in this market can majorly be attributed to the rising demand for automated and point-of-care Electrolyte Analyzer devices. Also, the market will be further driven by the growing number of patients being treated in ICUs, NICUs, and emergency departments; the …
- グローバル製薬の景況感レポート(2015年上半期)Summary “Pharmaceutical Industry Business Confidence Report H1 2015” is a new report by Kable that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the pharmaceutical industry. This report also examines executive opinions with regards to the current and future state of the economy and its effect on …
- オンコセルカ症(河川盲目症)(Onchocerciasis (River Blindness)):世界の治験レビュー2014年下半期版Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014" provides data on the Onchocerciasis (River Blindness) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Onchocerciasis (River Blindness). It inclu …
- 女性医療診断の世界市場ABSTRACTAbout Women's Health Diagnostics Technological advances such as integration of digital technology with diagnostic instrumentation, multiple technologies-based hematology analyzers, and quick monitoring of blood flow in deep tissues with real-time software correlators are boosting the growth of the IVD instruments market. The growing popularity of automation and technological advances have …